The Design, Synthesis, and Evaluation of Molecules That Enable or Enhance Cellular Uptake: Peptoid Molecular Transporters

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Nov 23

PMID 11087855

Citations 416

Authors

P A Wender

D J Mitchell

K Pattabiraman

E T Pelkey

L Steinman

J B Rothbard

Affiliations

Soon will be listed here.

Abstract

Certain proteins contain subunits that enable their active translocation across the plasma membrane into cells. In the specific case of HIV-1, this subunit is the basic domain Tat(49-57) (RKKRRQRRR). To establish the optimal structural requirements for this translocation process, and thereby to develop improved molecular transporters that could deliver agents into cells, a series of analogues of Tat(49-57) were prepared and their cellular uptake into Jurkat cells was determined by flow cytometry. All truncated and alanine-substituted analogues exhibited diminished cellular uptake, suggesting that the cationic residues of Tat(49-57) play a principal role in its uptake. Charge alone, however, is insufficient for transport as oligomers of several cationic amino acids (histidine, lysine, and ornithine) are less effective than Tat(49-57) in cellular uptake. In contrast, a 9-mer of l-arginine (R9) was 20-fold more efficient than Tat(49-57) at cellular uptake as determined by Michaelis-Menton kinetic analysis. The d-arginine oligomer (r9) exhibited an even greater uptake rate enhancement (>100-fold). Collectively, these studies suggest that the guanidinium groups of Tat(49-57) play a greater role in facilitating cellular uptake than either charge or backbone structure. Based on this analysis, we designed and synthesized a class of polyguanidine peptoid derivatives. Remarkably, the subset of peptoid analogues containing a six-methylene spacer between the guanidine head group and backbone (N-hxg), exhibited significantly enhanced cellular uptake compared to Tat(49-57) and even to r9. Overall, a transporter has been developed that is superior to Tat(49-57), protease resistant, and more readily and economically prepared.

Citing Articles

Egress-enhancing mutation reveals inefficiency of non-enveloped virus cell exit.

Rodriguez-Irizarry V, Maples R, Pfeiffer J bioRxiv. 2025; .

PMID: 40060481 PMC: 11888378. DOI: 10.1101/2025.02.25.640062.

ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion.

Duan Y, Hu Z, Han P, Lei B, Wang S, Wang Z Nat Cell Biol. 2025; .

PMID: 40033100 DOI: 10.1038/s41556-025-01627-8.

Exploiting Silica-Binding and Silica-Forming Proteins as Versatile Tools for One-Step Enzyme Immobilization on Siliceous Materials.

Lim G, Jo B Int J Mol Sci. 2025; 26(3).

PMID: 39941072 PMC: 11818168. DOI: 10.3390/ijms26031304.

A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice.

Tang X, Wang H, Yin Y, Zhong G Gene Ther. 2025; .

PMID: 39939797 DOI: 10.1038/s41434-025-00519-8.

Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner.

Qian X, Zhou Q, Ouyang Y, Wu X, Sun X, Wang S Proc Natl Acad Sci U S A. 2025; 122(5):e2412473122.

PMID: 39888917 PMC: 11804496. DOI: 10.1073/pnas.2412473122.

References

Nagahara H, Snyder E, Ho A, Latham D, Lissy N, Ezhevsky S . Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med. 1998; 4(12):1449-52. DOI: 10.1038/4042. View

Murphy J, Uno T, HAMER J, Cohen F, Dwarki V, Zuckermann R . A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proc Natl Acad Sci U S A. 1998; 95(4):1517-22. PMC: 19070. DOI: 10.1073/pnas.95.4.1517. View

Frankel A, Pabo C . Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988; 55(6):1189-93. DOI: 10.1016/0092-8674(88)90263-2. View

Heyden N, Lissy N, Ratner L, Dowdy S . Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med. 1999; 5(1):29-33. DOI: 10.1038/4710. View

Buschle M, Schmidt W, Zauner W, Mechtler K, Trska B, Kirlappos H . Transloading of tumor antigen-derived peptides into antigen-presenting cells. Proc Natl Acad Sci U S A. 1997; 94(7):3256-61. PMC: 20356. DOI: 10.1073/pnas.94.7.3256. View

Vives E, Brodin P, Lebleu B . A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997; 272(25):16010-7. DOI: 10.1074/jbc.272.25.16010. View

Mulders P, Pang S, Dannull J, Kaboo R, Hinkel A, Michel K . Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates. Cancer Res. 1998; 58(5):956-61. View

Heizmann G, Felder E . Synthesis of an N-3-guanidinopropylglycine (Narg) derivative as a versatile building block for solid-phase peptide and peptoid synthesis. Pept Res. 1994; 7(6):328-32. View

Colombo R, Atherton E, SHEPPARD R, Woolley V . 4-Chloromethylphenoxyacetyl polystyrene and polyamide supports for solid-phase peptide synthesis. Int J Pept Protein Res. 1983; 21(2):118-26. DOI: 10.1111/j.1399-3011.1983.tb03085.x. View

10.

Emi N, Kidoaki S, Yoshikawa K, Saito H . Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate. Biochem Biophys Res Commun. 1997; 231(2):421-4. DOI: 10.1006/bbrc.1997.6125. View

11.

Elliott G, OHare P . Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 1997; 88(2):223-33. DOI: 10.1016/s0092-8674(00)81843-7. View

12.

Fawell S, Seery J, Daikh Y, Moore C, Chen L, Pepinsky B . Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A. 1994; 91(2):664-8. PMC: 43009. DOI: 10.1073/pnas.91.2.664. View

13.

Kim D, Mitchell D, Brockstedt D, Fong L, Nolan G, Fathman C . Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J Immunol. 1997; 159(4):1666-8. View

14.

RYSER H, Shen W . Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc Natl Acad Sci U S A. 1978; 75(8):3867-70. PMC: 392889. DOI: 10.1073/pnas.75.8.3867. View

15.

Pooga M, Hallbrink M, Zorko M, Langel U . Cell penetration by transportan. FASEB J. 1998; 12(1):67-77. DOI: 10.1096/fasebj.12.1.67. View

16.

Rait A, Pirollo K, Will D, Peyman A, Rait V, Uhlmann E . 3'-End conjugates of minimally phosphorothioate-protected oligonucleotides with 1-O-hexadecylglycerol: synthesis and anti-ras activity in radiation-resistant cells. Bioconjug Chem. 2000; 11(2):153-60. DOI: 10.1021/bc990106n. View

17.

Derossi D, Chassaing G, Prochiantz A . Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 1998; 8(2):84-7. View

18.

Gius D, Ezhevsky S, Nagahara H, Wei M, Dowdy S . Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res. 1999; 59(11):2577-80. View

19.

RYSER H . A membrane effect of basic polymers dependent on molecular size. Nature. 1967; 215(5104):934-6. DOI: 10.1038/215934a0. View

20.

Shen W, RYSER H . Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci U S A. 1978; 75(4):1872-6. PMC: 392443. DOI: 10.1073/pnas.75.4.1872. View